22 results
8-K
EX-1.1
9fu8f67b
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
d46435v zjriryxox
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
rf6fm9z5cfbxli 38
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
ntkgct
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
dp6qgvmgw2100vk t7
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
u119y1bjfumq3po1
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
bqdt32at ht
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
nwygr
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-4.1
3h3y35 rog7
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
zofdvx vof871a
12 Apr 19
Prospectus supplement
4:39pm